CRTX Insider Trading Activity and SEC Form 4 Filings
CRTX insider trading summary
No open-market insider purchases or sales of Cortexyme, Inc. (CRTX) have been reported on SEC Form 4 in the past 12 months.
Latest CRTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 6, 2022 | Caryn Gordon McDowell | Chief Legal & Adm. Officer | Sell | $31K (10,800 @ $2.86) |
| Nov 12, 2021 | Stephen S. Dominy | Chief Scientific Officer | Buy | $11K (763 @ $14.40) |
| Oct 8, 2021 | Margaret McLoughlin | Director | Sell | $89K (1,000 @ $88.93) |
| Oct 5, 2021 | Christopher P. Lowe | COO & Chief Financial Officer | Sell | $489K (4,963 @ $98.50) |
| Aug 16, 2021 | Christopher P. Lowe | COO & Chief Financial Officer | Sell | $205K (2,077 @ $98.90) |
| Aug 16, 2021 | Christopher P. Lowe | COO & Chief Financial Officer | Sell | $107K (1,100 @ $97.28) |
| Aug 16, 2021 | Margaret McLoughlin | Director | Sell | $289K (3,056 @ $94.55) |
| Aug 16, 2021 | Christopher P. Lowe | COO & Chief Financial Officer | Sell | $224K (2,330 @ $96.32) |
| Aug 16, 2021 | Christopher P. Lowe | COO & Chief Financial Officer | Sell | $697K (7,335 @ $95.02) |
| Aug 16, 2021 | Christopher P. Lowe | COO & Chief Financial Officer | Sell | $863K (9,158 @ $94.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.